학술논문
Outcomes and Predictors of Perinatal Mortality in Fetuses With Ebstein Anomaly or Tricuspid Valve Dysplasia in the Current Era
Document Type
article
Author
Freud, Lindsay R; Escobar-Diaz, Maria C; Kalish, Brian T; Komarlu, Rukmini; Puchalski, Michael D; Jaeggi, Edgar T; Szwast, Anita L; Freire, Grace; Levasseur, Stéphanie M; Kavanaugh-McHugh, Ann; Michelfelder, Erik C; Moon-Grady, Anita J; Donofrio, Mary T; Howley, Lisa W; Tierney, Elif Seda Selamet; Cuneo, Bettina F; Morris, Shaine A; Pruetz, Jay D; van der Velde, Mary E; Kovalchin, John P; Ikemba, Catherine M; Vernon, Margaret M; Samai, Cyrus; Satou, Gary M; Gotteiner, Nina L; Phoon, Colin K; Silverman, Norman H; McElhinney, Doff B; Tworetzky, Wayne
Source
Circulation. 132(6)
Subject
Language
Abstract
BackgroundEbstein anomaly and tricuspid valve dysplasia are rare congenital tricuspid valve malformations associated with high perinatal mortality. The literature consists of small, single-center case series spanning several decades. We performed a multicenter study to assess the outcomes and factors associated with mortality after fetal diagnosis in the current era.Methods and resultsFetuses diagnosed with Ebstein anomaly and tricuspid valve dysplasia from 2005 to 2011 were included from 23 centers. The primary outcome was perinatal mortality, defined as fetal demise or death before neonatal discharge. Of 243 fetuses diagnosed at a mean gestational age of 27±6 weeks, there were 11 lost to follow-up (5%), 15 terminations (6%), and 41 demises (17%). In the live-born cohort of 176 live-born patients, 56 (32%) died before discharge, yielding an overall perinatal mortality of 45%. Independent predictors of mortality at the time of diagnosis were gestational age